Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Find effective wealth accumulation strategies designed specifically for young professionals. Start building your financial future today.
17,961 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Intraday spikes can be thrilling, but they’re not always meaningful. Learn why a stock popped today then often retrea...
A zero-premium Part D plan can still trigger the IRMAA surcharge, adding as much as $91 a month for certain retirees....
Cogent Communications stock crashed after a mixed quarter, delivering a revenue miss despite a narrower loss. This an...
A surge of progressive candidates backed by a Mamdani slate toppled two Democratic incumbents in a New York primary, ...
Looking for a retirement spot near major culture and opportunities without NYC prices? This guide spotlights two nort...
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
A notable stake increase in Shift4 Payments hints at growing conviction from Maestria Partners. This deep dive explai...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
Former President Donald Trump uses a housing-package signing delay to demand action on an elections bill while preser...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...